Excaliard Pharmaceuticals

About:

Excaliard is a biotechnology company developing antisense drugs for the local treatment of scarring and other fibrotic diseases.

Website: http://excaliard.com

Top Investors: Alta Partners, RiverVest, ProQuest Investments

Description:

Excaliard is a newly formed, venture capital-funded biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and other fibrotic diseases.

Total Funding Amount:

$15.5M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)excaliard.com

Founders:

Gordon Foulkes

Number of Employees:

Last Funding Date:

2007-11-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai